IDEA? A good 1:5 RR here.

Macroscopic Factors:
A will draw down from the macroscopic factors to this script. 10 yr TFT Bonds are around their crucial resistance and will likely witness a heavy selloff. The Indian indexes have filled the gap created on the budget and the following days now and there isn't a gap left to fill.

Similar Scripts:
Bharti Airtel (NSE:BHARTIARTL) experienced a massive volume around the closing on Friday, March 19. The recent report by Telcos are positive for all telecom companies.

Vodafone Idea is around very crucial support at 9.70. The script has bounced sharply by 0.9 to 1.2 Rs within two trading sessions from around this level. Since the RR is good on the trade, I reckon to have to trades.

For High-Risk Takers:
In this strategy the capital invested is small but you stand to lose your capital even if we happen to have a successful trade here, but late. Buy Mar 10 CE and hold it until expiry of if we hit 10.25. We will likely see 11.45 on the chart, however, for that you are advised to follow the medium risk taker's strategy.

For moderate risk takers:
F&O is typically for high risk appetite traders since your chances of losing your complete invested capital is very high and if you don't follow the price action and other economic indicators (alongside the RSI and MACD ), you are highly likely to fail. Buy IDEA Apr Fut at CMP or Apr 10 CE at CMP of 0.9. Exit when we close below 9.45 on the spot chart. This is our SL. The rest of the targets are mentioned on the charts. Reminder: If you take a Fut lot, you can rollover to May Fut eventually if the target takes longer and you won't be penalized for the time delay. Choice is yours.
Trade active: Made a high of 10.15 today. Target hit on the 10 CE on the next day itself. The target for this month closed. Bought Apr 10 CE on closing.
Trade closed: target reached: Target for March met.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.